SCHOTT Pharma
1SXP.DE
#3153
Rank
NZ$6.76 B
Marketcap
$44.89
Share price
1.08%
Change (1 day)
-21.29%
Change (1 year)

Revenue for SCHOTT Pharma (1SXP.DE)

Revenue in 2024 (TTM): NZ$1.67 Billion

According to SCHOTT Pharma's latest financial reports the company's current revenue (TTM ) is NZ$1.80 Billion. In 2023 the company made a revenue of NZ$1.55 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SCHOTT Pharma from 2023 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$1.67 B8.06%
2023 NZ$1.55 B